Tower to make $50m. rights offering

Each Tower shareholder and holder of eligible options would receive one right for each 138.98 ordinary shares or eligible options owned at the time of the offering.

By AVI KRAWITZ
December 19, 2005 08:07
tower semiconductor 88

semiconductor 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Tower Semiconductor Ltd. said late last week that the US Securities and Exchange Commission approved its proposed $50 million rights offering, to go into effect on December 20. Each Tower shareholder and holder of eligible options would receive one right for each 138.98 ordinary shares or eligible options owned at the time of the offering. Each right would entitle the holder to purchase 100 of Tower's US dollar denominated debentures for $100. The debentures would be convertible into Tower's ordinary shares at a rate of one ordinary share per $1.10 principal amount of debentures. The rights would be exercisable for through January 12. Shareholders have already committed to buy $25.5m. of bonds in offering, the company said.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS